COMMERCIAL SUPPORT

The Arizona Society of Pathologists thanks the commercial supporters listed below for their valued support of our 2023 Annual Meeting, to be held on Saturday, November 18 as a hybrid meeting.

 

PLATINUM LEVEL COMMERCIAL SUPPORTERS

 

Adaptative Biotechnologies

 

 

 

 

 

 

 

AstraZeneca

 

 

 

 

 

 

 

 

 

 

 

​AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit us at www.astrazeneca-us.com and www.azprecisionmed.com.

 

 

 

Blueprint Medicines

 

 

 

 

 

 

 

 

 

Castle Biosciences

 

 

 

 

 

 

 

 

 

 

 

 

Daiichi-Sankyo

 

 

 

 

 

 

 

 

 

 

 

 

 

Interpace Diagnostics

 

 

 

 

 

 

 

 

 

GOLD LEVEL COMMERCIAL SUPPORTERS

 

 

StatLab Medical Products

 

 

 

 

 

 

 

 

 

 

 

 

 

SILVER LEVEL COMMERCIAL SUPPORTERS

 

APS Medical Billing

 

 

 

 

 

 

 

 

 

 

Biocare Medical

 

 

 

 

 

 

 

 

 

 

Merck & Co., Inc.

                                                        Novartis Precision Medicine

 

Novartis Precision Medicine has one mission: to improve patient care by increasing the number of patients who are tested for each and every relevant, actionable biomarker. The path from testing, to diagnosis, to treatment is challenging to navigate. We understand the importance of clinical decisions and the complexity of making them. We can partner with you to provide our expertise in order to advance biomarker testing for patients.
 
That’s why our motto is “If you have testing questions, we have testing answers"
 
John Holton
+1 303 868 3956
john.holton_ext@novartis.com

Recordati Rare Diseases

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.